{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:46:48Z","timestamp":1793231208848,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.mcna.2022.10.017","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T17:13:55Z","timestamp":1675790035000},"page":"357-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Genitourinary Syndrome of Menopause"],"prefix":"10.1016","volume":"107","author":[{"given":"Shanice","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Nasseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahir","family":"Santiago-Lastra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mcna.2022.10.017_bib1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause N Y N"},{"issue":"6","key":"10.1016\/j.mcna.2022.10.017_bib2","doi-asserted-by":"crossref","first-page":"101595","DOI":"10.1016\/j.beem.2021.101595","article-title":"The role of hormone therapy in urogenital health after menopause","volume":"35","author":"Nappi","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mcna.2022.10.017_bib3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajog.2016.07.045","article-title":"Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management","volume":"215","author":"Gandhi","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.mcna.2022.10.017_bib4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/GME.0000000000000910","article-title":"Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause","volume":"24","author":"Labrie","year":"2017","journal-title":"Menopause N Y N"},{"issue":"1","key":"10.1016\/j.mcna.2022.10.017_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/13697137.2018.1529748","article-title":"Vaginal atrophy across the menopausal age: results from the ANGEL study","volume":"22","author":"Cagnacci","year":"2019","journal-title":"Climacteric J Int Menopause Soc"},{"issue":"11","key":"10.1016\/j.mcna.2022.10.017_bib6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/GME.0000000000001238","article-title":"Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause","volume":"25","author":"Labrie","year":"2018","journal-title":"Menopause N Y N"},{"issue":"2","key":"10.1016\/j.mcna.2022.10.017_bib7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/13697137.2015.1132199","article-title":"The role of local estrogen therapy in the management of pelvic floor disorders","volume":"19","author":"Tzur","year":"2016","journal-title":"Climacteric J Int Menopause Soc"},{"issue":"1","key":"10.1016\/j.mcna.2022.10.017_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.maturitas.2013.10.018","article-title":"Estrogenic action on innate defense mechanisms in the urinary tract","volume":"77","author":"L\u00fcthje","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.mcna.2022.10.017_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.maturitas.2017.02.004","article-title":"Preventing urinary tract infections after menopause without antibiotics","volume":"99","author":"Caretto","year":"2017","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.mcna.2022.10.017_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/GME.0b013e3182a4690b","article-title":"Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy","volume":"21","author":"Brotman","year":"2014","journal-title":"Menopause N Y N"},{"issue":"4 Suppl 1","key":"10.1016\/j.mcna.2022.10.017_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0090-4295(03)00676-9","article-title":"The role of estrogens in female lower urinary tract dysfunction","volume":"62","author":"Robinson","year":"2003","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.mcna.2022.10.017_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/jwh.2009.1384","article-title":"Recognizing and treating urogenital atrophy in postmenopausal women","volume":"19","author":"Goldstein","year":"2010","journal-title":"J\u00a0Womens Health"},{"issue":"5","key":"10.1016\/j.mcna.2022.10.017_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3949\/ccjm.85a.15081","article-title":"Genitourinary syndrome of menopause: common problem, effective treatments","volume":"85","author":"Phillips","year":"2018","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"10.1016\/j.mcna.2022.10.017_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/GME.0000000000001221","article-title":"A\u00a0systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause","volume":"26","author":"Biehl","year":"2019","journal-title":"Menopause N Y N"},{"issue":"9","key":"10.1016\/j.mcna.2022.10.017_bib15","doi-asserted-by":"crossref","first-page":"e0136265","DOI":"10.1371\/journal.pone.0136265","article-title":"Local oestrogen for pelvic floor disorders: a systematic review","volume":"10","author":"Weber","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.mcna.2022.10.017_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","article-title":"A\u00a0controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections","volume":"329","author":"Raz","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2022.10.017_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/gme.0b013e31823b8983","article-title":"Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women","volume":"19","author":"Griebling","year":"2012","journal-title":"Menopause N Y N"},{"issue":"3","key":"10.1016\/j.mcna.2022.10.017_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/SPV.0b013e3181ab4804","article-title":"Local effects of vaginally administered estrogen therapy: a review","volume":"15","author":"Krause","year":"2009","journal-title":"J\u00a0Pelvic Med Surg"},{"issue":"10204","key":"10.1016\/j.mcna.2022.10.017_bib19","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"10.1016\/j.mcna.2022.10.017_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/2053369118795349","article-title":"BMS - Consensus statement","volume":"24","author":"Pitkin","year":"2018","journal-title":"Post Reprod Health"},{"key":"10.1016\/j.mcna.2022.10.017_bib21","first-page":"djac112","article-title":"Systemic or vaginal hormone therapy after early breast cancer: a danish observational cohort study","volume":"20","author":"Cold","year":"2022","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.mcna.2022.10.017_bib22","first-page":"1","article-title":"Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study","volume":"28","author":"Mension","year":"2022","journal-title":"Climacteric J Int Menopause Soc"},{"issue":"Supplement 4","key":"10.1016\/j.mcna.2022.10.017_bib23","first-page":"e443","article-title":"Mp30-15 prevalence of urinary tract infections in women with genitourinary syndrome of menopause and the impact of vaginal prasterone on urinary tract infections","volume":"203","author":"Rubin \u2217","year":"2020","journal-title":"J\u00a0Urol"},{"issue":"8","key":"10.1016\/j.mcna.2022.10.017_bib24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/GME.0000000000002007","article-title":"Prasterone in the treatment of mild to moderate urge incontinence: an observational study","volume":"29","author":"Coll\u00e0 Ruvolo","year":"2022","journal-title":"Menopause N Y N"},{"issue":"2","key":"10.1016\/j.mcna.2022.10.017_bib25","first-page":"487","article-title":"The efficacy and safety of ospemifene in treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy: a systematic review and meta-analysis","volume":"11","author":"Cui","year":"2014","journal-title":"J\u00a0Sex Med"},{"issue":"6","key":"10.1016\/j.mcna.2022.10.017_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1517\/17425255.2010.487483","article-title":"Pharmacologic evaluation of ospemifene","volume":"6","author":"McCall","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"8","key":"10.1016\/j.mcna.2022.10.017_bib27","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/09513590.2018.1441398","article-title":"Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality?","volume":"34","author":"Schiavi","year":"2018","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.mcna.2022.10.017_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.esxm.2018.03.002","article-title":"Improvements to the vulva, vestibule, urethral meatus, and vagina in women treated with ospemifene for moderate to severe dyspareunia: a prospective vulvoscopic pilot study","volume":"6","author":"Goldstein","year":"2018","journal-title":"Sex Med"},{"issue":"3","key":"10.1016\/j.mcna.2022.10.017_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijwd.2016.05.003","article-title":"Vaginal rejuvenation using energy-based devices","volume":"2","author":"Karcher","year":"2016","journal-title":"Int J Womens Dermatol"},{"issue":"10","key":"10.1016\/j.mcna.2022.10.017_bib30","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/lsm.23126","article-title":"The effect of fractional CO2 laser treatment on the symptoms of pelvic floor dysfunctions: pelvic floor distress inventory-20 questionnaire","volume":"51","author":"Sipos","year":"2019","journal-title":"Lasers Surg Med"},{"issue":"10","key":"10.1016\/j.mcna.2022.10.017_bib31","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/lsm.22713","article-title":"Fractional CO2 laser of the vagina for genitourinary syndrome of menopause: Is the out-of-pocket cost worth the outcome of treatment?","volume":"49","author":"Lang","year":"2017","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.mcna.2022.10.017_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/IJWH.S158913","article-title":"Current treatment options for postmenopausal vaginal atrophy","volume":"10","author":"Naumova","year":"2018","journal-title":"Int J Womens Health"},{"issue":"3","key":"10.1016\/j.mcna.2022.10.017_bib33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.sxmr.2020.03.003","article-title":"Testosterone and vaginal function","volume":"8","author":"Maseroli","year":"2020","journal-title":"Sex Med Rev"},{"issue":"4","key":"10.1016\/j.mcna.2022.10.017_bib34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/theoncologist.2010-0435","article-title":"Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I\/II study","volume":"16","author":"Witherby","year":"2011","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.mcna.2022.10.017_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/sm2.22","article-title":"Breast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapy","volume":"2","author":"Dahir","year":"2014","journal-title":"Sex Med"},{"key":"10.1016\/j.mcna.2022.10.017_bib36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fendo.2019.00561","article-title":"Addressing vulvovaginal atrophy (VVA)\/genitourinary syndrome of menopause (GSM) for healthy aging in women","volume":"10","author":"Nappi","year":"2019","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.mcna.2022.10.017_bib37","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1097-0185(19991015)257:5<154::AID-AR3>3.0.CO;2-2","article-title":"The American Association of Clinical Anatomists (AACA): the other American anatomy association","volume":"257","author":"Dalley","year":"1999","journal-title":"Anat Rec"},{"issue":"5","key":"10.1016\/j.mcna.2022.10.017_bib38","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","article-title":"A\u00a0randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women","volume":"180","author":"Eriksen","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mcna.2022.10.017_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13697137.2020.1820478","article-title":"Vaginal lubricants and moisturizers: a review into use, efficacy, and safety","volume":"24","author":"Potter","year":"2021","journal-title":"Climacteric J Int Menopause Soc"},{"issue":"5","key":"10.1016\/j.mcna.2022.10.017_bib40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/13697137.2020.1724942","article-title":"Pelvic floor muscle training: mechanisms of action for the improvement of genitourinary syndrome of menopause","volume":"23","author":"Mercier","year":"2020","journal-title":"Climacteric J Int Menopause Soc"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522001596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712522001596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:47:42Z","timestamp":1758419262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712522001596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0025712522001596"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2022.10.017","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genitourinary Syndrome of Menopause","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2022.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}